NV
Northpond Ventures Portfolio holdings
AUM
$43.7M
This Quarter Return
-41.29%
1 Year Return
-34.02%
3 Year Return
-71.84%
5 Year Return
–
10 Year Return
–
AUM
$186M
AUM Growth
+$186M
(-35%)
Cap. Flow
+$29.6M
Cap. Flow
% of AUM
15.97%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
VIGL
Vigil Neuroscience
VIGL
|
$29.6M |
| 2 |
ISO
IsoPlexis Corporation Common Stock
ISO
|
$11.2K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DICE
1
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $63M | 33.95% | 3,292,871 | – | – |
|
|
TBIO
2
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $52.9M | 28.49% | 9,844,130 | – | – |
|
|
ISO
3
DELISTED
IsoPlexis Corporation Common Stock
ISO
| $30.2M | 16.28% | 8,808,531 +3,259 | +0% | +$11.2K |
|
|
VIGL
4
DELISTED
Vigil Neuroscience
VIGL
| $29.6M | 15.97% | +4,214,498 | New | +$29.6M |
|
5
Candel Therapeutics
CADL
$318M
| $9.85M | 5.31% | 1,935,215 | – | – |
|